AACE Clinical Case Reports (Jan 2015)

Clinical Case Report: LECT2-Associated Adrenal Amyloidosis

  • Mitra L. Rauschecker, MD,
  • Stephanie M. Cologna, PhD,
  • Paraskevi Xekouki, MD, DMedSci,
  • Naris Nilubol, MD,
  • Robert D. Shamburek, MD,
  • Maria Merino, MD,
  • Peter S. Backlund, PhD,
  • Alfred L. Yergey, PhD,
  • Electron Kebebew, MD,
  • James E. Balow, MD,
  • Constantine A. Stratakis, MD, DMedSci,
  • Smita Baid Abraham, MD

Journal volume & issue
Vol. 1, no. 1
pp. e59 – e67

Abstract

Read online

ABSTRACT: Objective: Leukocyte chemotactic factor-2 (LECT2)- associated amyloidosis is a newly discovered cause of amyloid and has thus far been reported to involve only the kidneys. We report a case of amyloidosis of the adrenal gland, along with involvement of the kidney, in a patient with primary aldosteronism.Methods: Tissue samples from the patient were analyzed using tandem mass spectrometry to identify the amyloid protein, followed by Western blot. DNA sequencing was performed to evaluate genetic polymorphisms.Results: Tandem mass spectrometry identified the amyloid protein as LECT2, and its identity was confirmed by Western blot. Genetic analysis revealed the patient to be homozygous for a genetic polymorphism of the LECT2 gene. Serum levels of LECT2 were undetectable, and no mutations were found in the CTNNB1, KCNJ5, ATP1A1, or ATP2B3 genes.Conclusion: This case appears to be the first published report to describe LECT 2-associated amyloidosis both outside of the kidney and within the adrenal gland.Abbreviations: CT computed tomography CTNNB1 catenin (cadherin-associated protein), beta 1 LDL low-density lipoprotein LECT2 leukocyte chemotactic factor-2 LECT2 AA LECT2-associated amyloid A amyloidosis PA primary aldosteronism SDS sodium dodecyl sulfate